Jackson Laureano is a Lexington, Kentucky based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Jackson Laureano is IP1871 for Ophthalmology in Kentucky. Jackson Laureano is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Jackson Laureano speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
800 Rose Street Mn 150, Lexington, Kentucky, 40506-0001
Phone:
859-323-6161
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1134877384
NPI Enumeration Date:
16 Mar, 2022
NPI Last Update On:
29 Sep, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jackson Laureano are as mentioned below.
License Number
Specialization
State
Status
IP1871
Ophthalmology
Kentucky
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
800 Rose Street Mn 150, Lexington, Kentucky
Zip:
40506-0001
Phone Number:
--
Fax Number:
--
Patients can reach Jackson Laureano at 800 Rose Street Mn 150, Lexington, Kentucky or can call to book an appointment on 859-323-6161. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.